These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 21788066)
1. Low TWEAK expression is correlated to the progression of squamous cervical carcinoma. Zou H; Wang D; Gan X; Jiang L; Chen C; Hu L; Zhang Y Gynecol Oncol; 2011 Oct; 123(1):123-8. PubMed ID: 21788066 [TBL] [Abstract][Full Text] [Related]
2. Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis. Peng QL; Shu XM; Tian XL; Lu X; Wang GC Arthritis Res Ther; 2014 Jan; 16(1):R26. PubMed ID: 24467773 [TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor-inducible 14 (Fn14) is expressed in the lower genital tract and may play a role in amplifying inflammation during infection. Han ES; Mekasha S; Ingalls RR J Reprod Immunol; 2010 Jan; 84(1):16-23. PubMed ID: 19963275 [TBL] [Abstract][Full Text] [Related]
4. [Expression of angiotensin II type 1 receptor in cervical squamous cell carcinoma and its clinical significance]. Liao YD; Xu H; Han Q; Lei J; Zhang YY; Wang ZH Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):360-4. PubMed ID: 17892132 [TBL] [Abstract][Full Text] [Related]
5. The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics. Perez JG; Tran NL; Rosenblum MG; Schneider CS; Connolly NP; Kim AJ; Woodworth GF; Winkles JA Oncogene; 2016 Apr; 35(17):2145-55. PubMed ID: 26300004 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible immediate early response protein 14 in oral squamous cell carcinoma and its implications. Acharya S; Prabhu P; Patil VS; Acharya AB; Nikhil K J Investig Clin Dent; 2019 Nov; 10(4):e12469. PubMed ID: 31541512 [TBL] [Abstract][Full Text] [Related]
7. TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization. Ameri H; Liu H; Liu R; Ha Y; Paulucci-Holthauzen AA; Hu S; Motamedi M; Godley BF; Tilton RG; Zhang W Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):801-13. PubMed ID: 24408972 [TBL] [Abstract][Full Text] [Related]
8. Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis. Dhruv H; Loftus JC; Narang P; Petit JL; Fameree M; Burton J; Tchegho G; Chow D; Yin H; Al-Abed Y; Berens ME; Tran NL; Meurice N J Biol Chem; 2013 Nov; 288(45):32261-32276. PubMed ID: 24056367 [TBL] [Abstract][Full Text] [Related]
9. Functional expression of TWEAK and the receptor Fn14 in human malignant ovarian tumors: possible implication for ovarian tumor intervention. Gu L; Dai L; Cao C; Zhu J; Ding C; Xu HB; Qiu L; Di W PLoS One; 2013; 8(3):e57436. PubMed ID: 23469193 [TBL] [Abstract][Full Text] [Related]
10. Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis. Kataria NG; Bartold PM; Dharmapatni AA; Atkins GJ; Holding CA; Haynes DR J Periodontal Res; 2010 Aug; 45(4):564-73. PubMed ID: 20546112 [TBL] [Abstract][Full Text] [Related]
11. The Src homology 3 domain-containing guanine nucleotide exchange factor is overexpressed in high-grade gliomas and promotes tumor necrosis factor-like weak inducer of apoptosis-fibroblast growth factor-inducible 14-induced cell migration and invasion via tumor necrosis factor receptor-associated factor 2. Fortin Ensign SP; Mathews IT; Eschbacher JM; Loftus JC; Symons MH; Tran NL J Biol Chem; 2013 Jul; 288(30):21887-97. PubMed ID: 23775076 [TBL] [Abstract][Full Text] [Related]
12. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression. Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130 [TBL] [Abstract][Full Text] [Related]
13. Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation. Wilhelm A; Shepherd EL; Amatucci A; Munir M; Reynolds G; Humphreys E; Resheq Y; Adams DH; Hübscher S; Burkly LC; Weston CJ; Afford SC J Pathol; 2016 May; 239(1):109-21. PubMed ID: 26924336 [TBL] [Abstract][Full Text] [Related]
14. TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis. Dharmapatni AA; Smith MD; Crotti TN; Holding CA; Vincent C; Weedon HM; Zannettino AC; Zheng TS; Findlay DM; Atkins GJ; Haynes DR Arthritis Res Ther; 2011 Mar; 13(2):R51. PubMed ID: 21435232 [TBL] [Abstract][Full Text] [Related]
15. TWEAK/Fn14 promotes apoptosis of human endometrial cancer cells via caspase pathway. Wang D; Fung JN; Tuo Y; Hu L; Chen C Cancer Lett; 2010 Aug; 294(1):91-100. PubMed ID: 20189297 [TBL] [Abstract][Full Text] [Related]
16. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells. Roos A; Dhruv HD; Mathews IT; Inge LJ; Tuncali S; Hartman LK; Chow D; Millard N; Yin HH; Kloss J; Loftus JC; Winkles JA; Berens ME; Tran NL Oncotarget; 2017 Feb; 8(7):12234-12246. PubMed ID: 28103571 [TBL] [Abstract][Full Text] [Related]
17. The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain. Haile WB; Echeverry R; Wu J; Yepes M J Cereb Blood Flow Metab; 2010 Jun; 30(6):1147-56. PubMed ID: 20068578 [TBL] [Abstract][Full Text] [Related]
18. TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain. Brown SA; Cheng E; Williams MS; Winkles JA PLoS One; 2013; 8(6):e65248. PubMed ID: 23750247 [TBL] [Abstract][Full Text] [Related]
19. Sex-determining region Y-related high mobility group box (SOX)-2 is overexpressed in cervical squamous cell carcinoma and contributes cervical cancer cell migration and invasion in vitro. Chang X; Zhang J; Huang C; Pang X; Luo Q; Zhang H; Zhang S Tumour Biol; 2015 Sep; 36(10):7725-33. PubMed ID: 25935536 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]